Literature DB >> 12892912

A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates.

Dmitri Zagorevskii1, Minghu Song, Curt Breneman, Yang Yuan, Tarra Fuchs, Kent S Gates, C Michael Greenlief.   

Abstract

Tandem mass spectrometry methods were used to study the sites of protonation and for identification of 3-amino-1,2,4-benzotriazine 1,4-dioxide (1, tirapazamine), and its metabolites (3-amino-1,2,4-benzotriazine 1-oxide (3), 3-amino-1,2,4-benzotriazine 4-oxide (4), 3-amino-1,2,4-benzotriazine (5), and a related isomer 3-amino-1,2,4-benzotriazine 2-oxide (6). Fragmentation pathways of 3 and 5 indicated the 4-N-atom as the most likely site of protonation. Among the N-oxides studied, the 4-oxide (4) showed the highest degree of protonation at the oxygen atom. The differences in collision-induced dissociation of isomeric protonated 1-, 2- and 4-oxides allowed for their identification by LC/MS/MS. Gas phase and liquid phase protonation of tirapazamine occurred exclusively at the oxygen in the 4-position. A loss of OH radical from these ions (2(+)) resulted in ionized 3. Neutralization-reionization mass spectrometry (NR MS) experiments demonstrated the stability of the neutral analogue of protonated tirapazamine in the gas phase in the micro s time-frame. A significant portion of the neutral tirapazamine radicals (2) dissociated by loss of hydroxyl radical during the NR MS event, which indicates that previously proposed mechanisms for redox-activated DNA damage are reasonable. The activation energy for loss of hydroxyl radical from activated tirapazamine (2) was estimated to be approximately 14 kcal mol(-1). Stable neutral analogues of [3 + H](+) and [5 + H](+) ions were also generated in the course of NR MS experiments. Structures of these radicals were assigned to the molecules having an extra hydrogen atom at one of the ring N-atoms. Quantum chemical calculations of protonated 1, 3, 4 and 5 and the corresponding neutrals were performed to assist in the interpretation of experimental results and to help identify their structures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892912     DOI: 10.1016/S1044-0305(03)00334-9

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  14 in total

Review 1.  Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia.

Authors:  W A Denny; W R Wilson
Journal:  Expert Opin Investig Drugs       Date:  2000-12       Impact factor: 6.206

2.  Studies of unusual simple molecules by neutralization-reionization mass spectrometry.

Authors:  F W McLafferty
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

3.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

4.  Modeling the action of an antitumor drug: a density functional theory study of the mechanism of tirapazamine.

Authors:  F Ban; J W Gauld; R J Boyd
Journal:  J Am Chem Soc       Date:  2001-08-01       Impact factor: 15.419

5.  3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).

Authors:  T Fuchs; G Chowdhury; C L Barnes; K S Gates
Journal:  J Org Chem       Date:  2001-01-12       Impact factor: 4.354

Review 6.  The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Authors:  J M Brown
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

7.  Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.

Authors:  S A Fitzsimmons; A D Lewis; R J Riley; P Workman
Journal:  Carcinogenesis       Date:  1994-08       Impact factor: 4.944

8.  Direct evidence for bimodal DNA damage induced by tirapazamine.

Authors:  J S Daniels; K S Gates; C Tronche; M M Greenberg
Journal:  Chem Res Toxicol       Date:  1998-11       Impact factor: 3.739

9.  Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.

Authors:  P Wardman; K I Priyadarsini; M F Dennis; S A Everett; M A Naylor; K B Patel; I J Stratford; M R Stratford; M Tracy
Journal:  Br J Cancer Suppl       Date:  1996-07

10.  Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.

Authors:  B G Siim; P L van Zijl; J M Brown
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

View more
  6 in total

Review 1.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

2.  Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.

Authors:  Michael W Epperly; Stephen Y Lai; Anthony J Kanai; Neal Mason; Brian Lopresi; Tracey Dixon; Darcy Franicola; Yunyun Niu; William R Wilson; Joel S Greenberger
Journal:  In Vivo       Date:  2010 Jan-Feb       Impact factor: 2.155

3.  DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2).

Authors:  Goutam Chowdhury; Venkatraman Junnotula; J Scott Daniels; Marc M Greenberg; Kent S Gates
Journal:  J Am Chem Soc       Date:  2007-09-27       Impact factor: 15.419

4.  Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxide antitumor agents: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide.

Authors:  Venkatraman Junnotula; Ujjal Sarkar; Sarmistha Sinha; Kent S Gates
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

Review 5.  Targeting the metabolic microenvironment of tumors.

Authors:  Kate M Bailey; Jonathan W Wojtkowiak; Arig Ibrahim Hashim; Robert J Gillies
Journal:  Adv Pharmacol       Date:  2012

Review 6.  Microenvironment and radiation therapy.

Authors:  Michio Yoshimura; Satoshi Itasaka; Hiroshi Harada; Masahiro Hiraoka
Journal:  Biomed Res Int       Date:  2012-12-04       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.